diaziquone has been researched along with Acute Lymphoid Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balis, FM; Berg, SL; Doherty, K; Gillespie, A; Holcenberg, J; Murphy, RF; Reaman, G; Sato, J; Steinherz, P; Zimm, S | 1 |
| Lee, EJ; Reck, K; Schiffer, CA | 1 |
| Bell, B; Castleberry, R; Cushing, B; Falletta, JM; Krance, RA; Lauer, S; Mahoney, DH | 1 |
1 trial(s) available for diaziquone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
2 other study(ies) available for diaziquone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Continuous infusion diaziquone and etoposide: a phase I study in adult patients with acute leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Blast Crisis; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |